CMES10 New Frontiers in Osteoporosis: Targets in Bone Remodeling

Program: CMES Ancillary Events
Clinical Session
Sunday, April 3, 2016: 5:45 AM-8:00 AM
Pacific Ballroom (The Renaissance)
Supported by educational grants from Amgen, Inc. and Merck & Co., Inc.

Registration is required for this session:
Learning Objectives:

Upon completion of this activity, participants should be better able to:

  • Summarize current insights in the pathways that regulate bone remodeling and the underlying pathophysiology of osteoporosis
  • Assess patients for osteoporosis and apply current state of care methods taking known limitations into consideration
  • Discuss the mechanism of action and current findings of new and emerging osteoporosis therapies
  • Recognize the benefits, limitations of on new and emerging osteoporosis therapies, and potential impact of ongoing trials on practice

6:00 AM

Michael R McClung, MD, Oregon Osteoporosis Center, Portland, OR
Disclosures:
MRM: Scientific Board Member, Amgen, Speaker, Amgen, Scientific Board Member, Merck & Co..
6:05 AM

Paul D Miller, MD, Colorado Center for Bone Research, Lakewood, CO
Nothing to Disclose: PDM
6:30 AM

Bente Lomholt Langdahl, PhD, DMSc, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Disclosures:
BLL: Advisory Group Member, Merck & Co., Advisory Group Member, Eli Lilly & Company, Researcher, Eli Lilly & Company, Clinical Researcher, Eli Lilly & Company, Clinical Researcher, Merck & Co., Advisory Group Member, Amgen, Clinical Researcher, Amgen, Researcher, Novo Nordisk.
6:50 AM

Benjamin Zev Leder, MD, Department of Medicine, Harvard Medical School, Boston, MA
Disclosures:
BZL: Clinical Researcher, Amgen, Advisory Group Member, Amgen, Advisory Group Member, Merck & Co., Clinical Researcher, Lilly USA, LLC, Advisory Group Member, Lilly USA, LLC.
7:10 AM

Michael R McClung, MD, Oregon Osteoporosis Center, Portland, OR
Disclosures:
MRM: Scientific Board Member, Amgen, Speaker, Amgen, Scientific Board Member, Merck & Co..
See more of: CMES Ancillary Events